Filing Details
- Accession Number:
- 0001127602-22-026898
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-12-05 16:55:14
- Reporting Period:
- 2022-12-01
- Accepted Time:
- 2022-12-05 16:55:14
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1100682 | Charles River Laboratories International Inc. | CRL | Services-Commercial Physical & Biological Research (8731) | 061397316 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1767215 | W Joseph Laplume | 251 Ballardvale Street Wilmington MA 01887 | Evp, Corp Strategy & Develop | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-12-01 | 6,409 | $109.34 | 26,641 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-12-01 | 1,138 | $223.06 | 25,503 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-12-01 | 4,165 | $224.41 | 21,338 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-12-01 | 1,106 | $224.85 | 20,232 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (Right to Buy) | Disposition | 2022-12-01 | 6,409 | $0.00 | 6,409 | $109.34 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2019-02-23 | 2023-02-23 | No | 4 | M | Direct |
Footnotes
- This transaction was executed in multiple trades at prices ranging from $222.66 to $223.37. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $223.68 to $224.63. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $224.66 to $225.16. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
